05/23-25/2024.

Athens Concert Hall, Hellas

IASIS PHARMA participated in the 3rd Innovation@ASygros Congress held on May 23 – 25, 2024 at the Concert Hall in Athens.

The conference was organized by the First University Clinic of Venereal and Skin Diseases of the Andreas Sygros Hospital.

Greek Dermatologists attended the congress and had the chance to visit IASIS PHARMA exhibition stand and got informed of 3 important IASIS Dermatological products:

• Isotroin^®/ Isotretinoin (at the new & unique 30mg dosage) indicated for Severe forms of Acne that are resistant to treatment with systemically administered antibiotics and topical therapy. Isotroin® 30mg  is added to the range of the other Isotroin® strengths  (10mg, 20mg & 40mg).
• Combi^®, a combination of fluprednidene (1mg) + miconazole (20mg) cream for the treatment of Inflammatory Dermatomycoses.
• Modiwart^®/Ιmiquimod (12,5mg/sachet), an innovative modifier of the immune response system indicated for the treatment of: External Genital Warts, Superficial Basal Cell Carcinomas and Aktinic Keratoses.